[{"indications": "Indications\u00a0\n(From Anthracycline side-effects: British National Formulary)\nAnthracycline side-effects and under\r\npreparations", "name": "DEXRAZOXANE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.1 Cytotoxic drugs", "Treatment for cytotoxic-induced side-effects", "Anthracycline side-effects", "DEXRAZOXANE"], "cautions": "Cautions\u00a0\n(From Anthracycline side-effects: British National Formulary)\nAnthracycline side-effects; monitor full blood count", "side-effects": "Side-effects\u00a0nausea, vomiting, dyspepsia, abdominal pain, diarrhoea,\r\nstomatitis, dry mouth, anorexia; dyspnoea; dizziness, syncope, asthenia,\r\nparaesthesia, tremor, fatigue, drowsiness; pyrexia; vaginal haemorrhage;\r\nmyalgia; blood disorders (including anaemia, leucopenia, neutropenia,\r\nthrombocytopenia, and increased myelosuppression); alopecia, pruritus;\r\nperipheral oedema, injection-site reactions including phlebitis; also reported  secondary malignancies", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/200214.htm", "doses": ["See under preparations", "prevention of anthracycline-induced cardiotoxicity, adult over 18 years, by intravenous infusion (30 minutes before anthracycline administration), 10 times the doxorubicin-equivalent\r\ndose or 10 times the epirubicin-equivalent dose"], "pregnancy": "Pregnancy\u00a0avoid unless essential (toxicity in animal studies); ensure effective contraception during and for at least\r\n3 months after treatment in men and women"}]